earnings reports," said Wyss. Ahead of Friday's opening bell, Dow components Caterpillar (CAT, Fortune 500) and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MERCK & CO.
Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.
Merck & Co. is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
967 news
and
178 blog
items.
Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from
like-minded professionals.
News
Recent news on this topic.
first-quarter profit of $1.84 a share, more than the $1.31 average estimate in a Bloomberg survey. Merck & Co.
first-quarter profit jumped as the drug maker registered increased sales and accounting adjustments took less of a toll.
May 20, 2008, driven by upbeat corporate results. Ahead of the market open on Friday, Caterpillar, Chevron and Merck...
April 29 (Bloomberg) -- Merck & Co., the second-largest U.S. drugmaker, reported first-quarter profit that topped...
Merck & Co (MRK.N) reported higher-than-expected first-quarter earnings, fueled by strong sales of its drugs for...
NEW YORK (TheStreet) -- Drug giant Merck(MRK) was rising 1.9% to $36.45 in premarket trading Friday after reporting...
NEW YORK (MarketWatch) -- Merck & Co. (NYSE:MRK
WHITEHOUSE STATION, N.J. ? Merck & Co. says its first-quarter profit more than tripled despite only slightly higher...
shares are expected to see active trade in Friday��s session are blue chips Caterpillar Inc., Chevron Corp.
reports, along with Microsofts late Thursday results, will probably drive the market direction. Among them:...
are expected to see active trade in Friday���s session are blue chips Caterpillar Inc., Chevron Corp. and Merck &...
Inc.���s business barometer and the Thomson Reuters/University of Michigan April final index of consumer sentiment for...
mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...
Extract not available.
mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...
Here are sales figures for the first quarter for Merck & Co.'s 10 top-selling drugs:PRODUCT NAME CONDITION/USE 1Q...
mixed earnings reports and disappointing GDP and jobless claims reports.Companies: Dow components Chevron (CVX, Fortune...
C virus offers an advance over the current decade-old treatment that cures only a minority of patients, maker Merck...
that it opposed the transaction because it believes that ���the passive drug royalties which Celera owns, associated...
costs, while generic competition for previously big-selling drugs limited sales growth to 1%. The results exceeded...
of all prescriptions, but four of the most commonly prescribed branded medications, Pfizer's Lipitor, AstraZeneca's...
S. stocks held their ground in midday trading on Friday, following upbeat earnings reports from Caterpillar Inc.
Chevron earnings up 36% on higher oil prices, better margins; Caterpillar 1Q revenue up 57% on stronger sales; Merck...
PROFIT SPIKE: Merck & Co.'s first-quarter profit more than tripled on lower costs from integrating Schering-Plough...
Top Sources: Merck & Co.
- Reuters
- BusinessWeek
- Philadelphia Inquirer
- MarketWatch
- Financial Times
- Wall Street Journal Online
- businesswire.com
- latimes.com
- Economictimes
- inpharm.com
account